TWA
FCSC

TCI Wealth Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

TCI Wealth Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed – – 1771
2018
Q3 		$0 Hold
200
– – ﹤0.01% 1657
2018
Q2 		$1K Hold
200
– – ﹤0.01% 1462
2018
Q1 		$1K Sell
200
-80
-29% -$262 ﹤0.01% 1310
2017
Q4 		$1K Buy
280
+200
+250% +$1.75K ﹤0.01% 1334
2017
Q3 		$1K Hold
80
– – ﹤0.01% 1274
2017
Q2 		$2K Buy
80
+47
+142% +$580 ﹤0.01% 1058
2017
Q1 		$0 Hold
33
– – ﹤0.01% 1424
2016
Q4 		$0 Sell
33
-14
-30% -$150 ﹤0.01% 1493
2016
Q3 		$1K Sell
47
-66
-58% -$979 ﹤0.01% 1290
2016
Q2 		$2K Buy
113
+66
+140% +$2.06K ﹤0.01% 990
2016
Q1 		$2K Buy
47
+14
+42% +$559 ﹤0.01% 1001
2015
Q4 		$2K Sell
33
-14
-30% -$1.01K ﹤0.01% 903
2015
Q3 		$3K Sell
47
-13
-22% -$1.15K ﹤0.01% 757
2015
Q2 		$5K Buy
60
+33
+122% +$2.22K ﹤0.01% 666
2015
Q1 		$2K Buy
+27
New +$1.74K ﹤0.01% 771

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TCI Wealth Advisors's FCSC Position: Q4 2018 in Review

TCI Wealth Advisors sold out of Fibrocell Science Inc. (FCSC) in Q4 2018, closing a stake of 200 shares.

TCI Wealth Advisors first reported a position in FCSC in Q1 2015 and held it in 15 quarters. The position peaked at $5K in Q2 2015. 26 funds tracked by Wall St. Rank hold FCSC as of Q4 2018.

  • TCI Wealth Advisors reported no remaining Fibrocell Science Inc. position as of Q4 2018 after selling out during the quarter.
  • TCI Wealth Advisors sold 200 Fibrocell Science Inc. shares in Q4 2018.
  • TCI Wealth Advisors first reported a position in Fibrocell Science Inc. in Q1 2015 and held it in 15 quarters.
  • TCI Wealth Advisors's Fibrocell Science Inc. position peaked at $5K in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2018.

Based on TCI Wealth Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.